<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT02488603</url>
  </required_header>
  <id_info>
    <org_study_id>NCCKorea</org_study_id>
    <nct_id>NCT02488603</nct_id>
  </id_info>
  <brief_title>Decision Aids for Tamoxifen Treatment in Breast Cancer Patients</brief_title>
  <official_title>Utilization of Decision Aids for Tamoxifen Treatment in Breast Cancer Patients: A Randomized Controlled Trial.</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>National Cancer Center, Korea</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>National Cancer Center, Korea</source>
  <brief_summary>
    <textblock>
      This is an educational intervention study for breast cancer patients who undergo tamoxifen
      treatment. The purpose of the study is to assess the impact of decision aids (DA) on the
      patients' decision-making process, compliance on drug, and knowledge regarding tamoxifen
      treatment. Patients will randomly assign to DA group or conventional group. Both groups will
      have baseline questionnaire surveys before starting tamoxifen treatment, and 4 weeks later
      follow-up questionnaire surveys.
    </textblock>
  </brief_summary>
  <overall_status>Not yet recruiting</overall_status>
  <start_date>August 2015</start_date>
  <primary_completion_date type="Anticipated">August 2018</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <masking>Single (Participant)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Change in Knowledge of Tamoxifen Scale</measure>
    <time_frame>baseline, 4weeks later</time_frame>
  </primary_outcome>
  <secondary_outcome>
    <measure>Decisional Conflict Scale</measure>
    <time_frame>baseline, 4weeks later</time_frame>
    <description>Assess the decisional conflict regarding tamoxifen treatment</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Satisfaction with Decision Questionnaire</measure>
    <time_frame>baseline, 4weeks later</time_frame>
    <description>Assess the satisfaction with decision to undergo tamoxifen treatment</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>EORTC QLQ-C30 Questionnaire</measure>
    <time_frame>baseline, 4weeks later</time_frame>
    <description>Assess the quality of life before and during tamoxfen treatment</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>EQ-5D Questionnaire</measure>
    <time_frame>baseline, 4weeks later</time_frame>
    <description>Assess the quality of life before and during tamoxfen treatment</description>
  </secondary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Anticipated">360</enrollment>
  <condition>Breast Cancer</condition>
  <arm_group>
    <arm_group_label>Decision aids</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
  </arm_group>
  <arm_group>
    <arm_group_label>usual care</arm_group_label>
    <arm_group_type>No Intervention</arm_group_type>
  </arm_group>
  <intervention>
    <intervention_type>Behavioral</intervention_type>
    <intervention_name>Decision aids (tamoxifen-related educational materials in brochure or mobile app)</intervention_name>
    <description>Decision aids (tamoxifen-related educational materials in brochure or mobile app)</description>
    <arm_group_label>Decision aids</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>tamoxifen</intervention_name>
    <arm_group_label>Decision aids</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Breast cancer patients who are recommended to undergo tamoxifen treatment in National
             Cancer Center, Korea

          -  - Age at least 18 years and more

        Exclusion Criteria:

          -  Age under 18 years

          -  Inability to read or speak Korean

          -  Disagree to provide a written informed consent
      </textblock>
    </criteria>
    <gender>Female</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>Accepts Healthy Volunteers</healthy_volunteers>
  </eligibility>
  <verification_date>June 2015</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>June 25, 2015</study_first_submitted>
  <study_first_submitted_qc>July 1, 2015</study_first_submitted_qc>
  <study_first_posted type="Estimate">July 2, 2015</study_first_posted>
  <last_update_submitted>July 1, 2015</last_update_submitted>
  <last_update_submitted_qc>July 1, 2015</last_update_submitted_qc>
  <last_update_posted type="Estimate">July 2, 2015</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>National Cancer Center, Korea</investigator_affiliation>
    <investigator_full_name>Eun Sook Lee</investigator_full_name>
    <investigator_title>MD, PhD</investigator_title>
  </responsible_party>
  <keyword>Breast Neoplasms</keyword>
  <keyword>Tamoxifen</keyword>
  <keyword>Decision Aids</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Breast Neoplasms</mesh_term>
  </condition_browse>
  <intervention_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Tamoxifen</mesh_term>
  </intervention_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

